vimarsana.com
Home
Live Updates
Regulators Approve Impella 5.5 With SmartAssist in Japan and
Regulators Approve Impella 5.5 With SmartAssist in Japan and
Regulators Approve Impella 5.5 With SmartAssist in Japan and Hong Kong; US FDA Grants Impella BTR Conditional IDE Approval for First-in-Human Early Feasibility Study
Regulators in three countries have granted approvals to Impella surgical products, as Abiomed continues to execute its strategy for sustainable growth with new products, new indications and new... | January 10, 2022
Related Keywords
Japan ,
United States ,
Hong Kong ,
Massachusetts ,
Japanese ,
Michaelr Minogue ,
,
Abiomed ,
Hong Kong Medical Device Division ,
Drug Administration ,
Devices Agency ,
Abiomed Inc ,
Japan Pharmaceuticals ,
Early Feasibility Study ,
Investigational Device Exemption ,
Medical Devices Agency ,
Medical Device Division ,
Business Wire ,
Chief Executive ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Regulators ,
N ,
Three ,
Countries ,
Wave ,
Granted ,
Approvals ,
O ,
Impella ,
Urgical ,
Us ,
Ontinues ,
Execute ,
Its ,
Strategy ,
Or ,
Ustainable ,
Growth ,
Ith ,
Few ,
Indications ,
Nd Abmd Us0036541003 ,